Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years.
Zhu F, Li J, Hu Y, Zhang X, Yang X, Zhao H, Wang J, Yang J, Xia G, Dai Q, Tang H, Suryakiran P, Datta SK, Descamps D, Bi D, Struyf F.
Zhu F, et al.
Hum Vaccin Immunother. 2014;10(7):1795-806. doi: 10.4161/hv.28702.
Hum Vaccin Immunother. 2014.
PMID: 25424785
Free PMC article.
Clinical Trial.